Serenoa repens
Serenoa repens · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Serenoa repens, commonly known as saw palmetto, is a botanical species primarily utilized for its medicinal fruit. The plant's extracts contain bioactive compounds such as beta-sitosterol, fatty acids, manans, and lauric acid. These chemical constituents allow the plant to function as an antioxidant and an inhibitor of 5-alpha-reductase, 11B-HSD, and 5-HT. Consequently, preparations like Permixon are frequently employed to manage conditions such as Benign Prostatic Hyperplasia and Benign Prostatic Hypertrophy. These therapeutic applications are particularly effective in alleviating lower urinary tract symptoms and nocturia.
- Synonyms
- Corypha Obliqua · Corypha Repens · 6 more
- Common names
- Not available
- Family
- Arecaceae
- Distribution
- Not available
- Plant Parts
- Fruit
Classification
Common Names
Serenoa repens is a versatile plant recognized by a diverse array of names across different languages and regions. In English-speaking areas, it is most widely known as the Saw Palmetto, though it is also referred to as the Palmier de Floride. Its international presence is reflected in names such as the Lithuanian Gulsčioji serenoja and the German Sägepalme. Additionally, it is identified in certain contexts as the Strauchpalmettopalme. These various common names highlight the plant's global botanical significance and cultural reach.
Sources: Catalogue of Life (COL)
Synonyms
Serenoa repens is a fascinating subject in botanical studies due to the complex web of taxonomic synonyms associated with its name. Historical records link this species to various other classifications, such as Brahea serrulata and Chamaerops serrulata. Researchers have also noted connections to Corypha obliqua and Corypha repens within older botanical literature. Furthermore, the name Diglossophyllum serrulatum has been utilized in previous descriptions of the plant. Navigating these overlapping relationships is essential for anyone seeking to accurately identify this specific species.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Serenoa repens is a unique botanical specimen that belongs to the vast kingdom Plantae. Within this kingdom, it is classified under the class Equisetopsida, marking its fundamental biological identity. The plant is further organized into the order Arecales, which helps define its evolutionary lineage. Moving down the taxonomic hierarchy, it is situated within the family Arecaceae, a group known for its diverse palm species. Finally, this plant is specifically categorized under the genus Serenoa, distinguishing it from all other related flora.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Arecales |
| Family | Arecaceae |
| Genus | Serenoa |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Serenoa repens is a distinctive plant species primarily found within the diverse landscapes of North America. Its natural distribution is concentrated throughout the Southeastern United States, where it thrives in specific coastal and lowland environments. Within this region, the plant is commonly documented across the state of Florida and throughout Georgia. It also maintains a significant presence in the southern reaches of Alabama and Mississippi. Finally, its habitat extends westward into the coastal areas of Louisiana, marking its broad geographic footprint.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Serenoa repens exhibits a tree-like growth form that allows it to stand as a self-supporting specimen in its natural habitat. This resilient plant reaches a maximum height of approximately 4.555 meters. Its structural integrity ensures it remains upright and stable throughout its life cycle.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Serenoa repens has been identified as a medicinal plant capable of providing significant antioxidant activity to support cellular health. In the context of male reproductive health, maintaining a balance between reactive oxygen species and antioxidant levels is crucial for protecting Leydig cells. Oxidative stress can impair these cells, leading to issues with steroidogenesis and potential infertility. Research suggests that the protective or restorative effects observed in these cells are directly attributed to the antioxidant content found in various plant extracts. Therefore, utilizing Serenoa repens at an optimal concentration may serve as a valuable strategy for managing oxidative stress and maintaining cellular function.
Compounds
Serenoa repens is a highly valued medicinal plant recognized for its therapeutic potential in addressing urological disorders such as benign prostatic hyperplasia. The plant is chemically complex, containing essential bioactive compounds including beta-sitosterol and various fatty acids. Detailed chemical analyses have identified specific constituents such as lauric acid and polyprenols within its structure. Additionally, the presence of mannans offers promising new perspectives for applications in the cosmeceutical field. By utilizing green extraction strategies, researchers can effectively harness these diverse components to promote more sustainable and waste-free pharmaceutical practices.
Conditions
Serenoa repens is an effective agent for treating benign prostatic hyperplasia (BPH) and benign prostatic hypertrophy. This plant is also utilized to treat lower urinary tract symptoms (LUTS) by improving urinary flow and reducing nocturia. Research indicates that its extracts can treat contractions of the rat prostate gland through various pharmacological mechanisms. Clinical evidence supports its use in managing the discomfort and symptoms associated with benign prostatic hyperplasia. Consequently, Serenoa repens serves as a well-tolerated option for addressing these specific prostatic and urological conditions.
Preparations
Serenoa repens is prepared as extract, extracts, and herbal extracts for various therapeutic applications. Specifically, Serenoa repens is prepared as extract (Permixon) to investigate its effects on experimental prostate enlargement in rats. These different preparations of the plant are studied for their roles in treating benign prostatic hyperplasia and managing hair loss. The research highlights how these preparations, whether used as lyposterolic or lipidosterolic extracts, impact hormonal levels and prostate health. Overall, the various forms in which Serenoa repens is prepared as extract serve as significant subjects in both clinical and experimental studies.
Parts used
Serenoa repens is a highly valued medicinal plant that produces specialized fruits containing a diverse array of bioactive compounds. Scientific analysis of these fruits has identified numerous steam-volatile components, with lauric acid serving as a primary constituent. Beyond their traditional use in treating urological disorders, the fruits offer significant potential for sustainable pharmaceutical manufacturing. Recent research into green extraction strategies highlights how residues from the fruit can be repurposed to recover valuable fatty acids and polyprenols. By utilizing these diverse chemical profiles, researchers aim to promote near-zero waste practices while expanding the plant's applications in the biomedical and cosmeceutical fields.